Threes Company: Regulation of Cell Fate by Statins
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
145-163
Author(s):
Joannis E. Vamvakopoulos
ADAM-Integrin Interactions: Potential Integrin Regulated Ectodomain Shedding Activity
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
837-847
Author(s):
Lance C. Bridges and Ron D. Bowditch
TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
933-944
Author(s):
G. Fiorucci, S. Vannucchi, Maria V. Chiantore, Zulema A. Percario, E. Affabris and G. Romeo
Anti-Inflammatory Effects of Intravenous Anesthetics on Endotoxemia
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
5
Page:
241-245
Author(s):
Takumi Taniguchi and Ken Yamamoto
CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
109-118
Author(s):
E. Lazzeri and P. Romagnani
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
115-130
Author(s):
Mohanraj Dhanabal, Mike Jeffers and William J. LaRochelle
Recent Advances in Pretargeted Radioimmunotherapy
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
319-338
Author(s):
A. Gruaz-Guyon, O. Raguin and J. Barbet
Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Journal:
Current Gene Therapy
Volume:
5
Page:
11-24
Author(s):
L. Citti and G. Rainaldi
Antibody Engineering, Virus Retargeting and Cellular Immunotherapy: One Ring to Rule Them All?
Journal:
Current Gene Therapy
Volume:
5
Page:
63-70
Author(s):
Laura Sanz, Jian Qiao, Richard G. Vile and Luis Álvarez-Vallina
In Situ Gene Therapy for Prostate Cancer
Journal:
Current Gene Therapy
Volume:
5
Page:
111-119
Author(s):
Takefumi Satoh, Akira Irie, Shin Egawa and Shiro Baba